Browsing by Subject "Antineoplastic agents."
Now showing items 1-2 of 2
-
A current insight into Aurora kinase inhibitors and their potential as anticancer agents
(Brac University, 2024-03)The Aurora kinases, comprising Aurora A, Aurora B, and Aurora C, constitute a family of serine/threonine protein kinases that plays a fundamental role in ensuring precise mitotic progression, regulating multiple phases of ... -
A review on newly approved PARP inhibitors: Talazoparib and Olaparib
(Brac University, 2024-01)This review delves into the intricate landscape of Poly ADP-ribose polymerase (PARP) inhibitors, specifically focusing on two notable contenders in cancer therapy – Talazoparib and Olaparib. By targeting the DNA Damage ...
